Synthesis and in vitro and in vivo evaluation of manganese(III) porphyrin–dextran as a novel MRI contrast agent
Authors:
- Hao LeiHLHao Lei
- Zao-Ying LiZLZao-Ying Li
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (23) , 6675-6678
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Indications for body MRI: Part I. Upper abdomen and renal imagingEuropean Journal of Radiology, 2008
- Comparison between Gd-DTPA and several bisamide derivatives as potential MRI contrast agentsBioorganic & Medicinal Chemistry, 2003
- Extracellular MRI Contrast Agents Based on Gadolinium2002
- Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsChemical Reviews, 1999
- Subcellular distribution of Al, Cu, Mg, Mn and other elements in the human liverAnalytical and Bioanalytical Chemistry, 1999
- Metalloporphyrin Contrast Enhancement of Tumors in Magnetic Resonance Imaging A Study of Human Carcinoma, Lymphoma, and Fibrosarcoma in MiceInvestigative Radiology, 1987
- Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- Tissue distribution and stability of metalloporphyrin MRI contrast agentsMagnetic Resonance in Medicine, 1987
- Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.Proceedings of the National Academy of Sciences, 1986
- Tumor Detection by Nuclear Magnetic ResonanceScience, 1971